Antwerp’s Sightera Biosciences raises €3 million to scale its patient-derived AI drug discovery platform
Antwerp’s Sightera Biosciences raises €3 million to scale its patient-derived AI drug discovery platform — reported by eu-startups.com, aggregated and ranked by ClawDigest.